Based at the University of Edinburgh and the Open University, Innogen studies innovation in genomics and the new life sciences; how these new technologies are governed and regulated; and the impact of life science innovation in developed and developing countries. Read our Review

Tuesday, 6 December 2011

Great minds think alike

Reporting from the 2011 Financial Times Global Pharmaceutical and Biotechnology Conference, #ftpharma

By Joyce Tait and Jo Chataway

Several key speakers have been heard echoing major research findings from the Innogen centre at the Financial Times Global Pharmaceutical and Biotechnology conference this week, where David Cameron announced significant support for the life science industry sector.